ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX)

CUSIP: 45256X103

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
1,124,549,707
Total 13F shares
61,630,296
Share change
-3,644,161
Total reported value
$389,584,078
Put/Call ratio
275%
Price per share
$6.32
Number of holders
188
Value change
-$21,451,973
Number of buys
101
Number of sells
67

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 45256X103?
CUSIP 45256X103 identifies IBRX - ImmunityBio, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of IBRX - ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
STATE STREET CORP
13F
Company
1.3%
14,184,277
$76,169,567 31 Mar 2024
13F
VANGUARD GROUP INC
13F
Company
1.2%
13,539,590
$72,707,598 31 Mar 2024
13F
BlackRock Finance, Inc.
13F
Company
0.92%
10,375,311
$55,715,419 31 Mar 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.31%
3,481,386
$18,697,626 31 Mar 2024
13F
CREDIT SUISSE AG/
13F
Company
0.14%
1,548,826
$8,317,196 31 Mar 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.13%
1,435,746
$7,709,956 31 Mar 2024
13F
NORTHERN TRUST CORP
13F
Company
0.12%
1,310,789
$7,038,937 31 Mar 2024
13F
Rafferty Asset Management, LLC
13F
Company
0.12%
1,310,390
$7,036,794 31 Mar 2024
13F
Invesco Ltd.
13F
Company
0.11%
1,267,142
$6,804,553 31 Mar 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.11%
1,215,381
$6,526,596 31 Mar 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.1%
1,171,212
$6,289,408 31 Mar 2024
13F
CITIGROUP INC
13F
Company
0.1%
1,128,446
$6,059,755 31 Mar 2024
13F
PERCEPTIVE ADVISORS LLC
13F
Company
0.09%
1,052,887
$5,654,003 31 Mar 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.09%
1,036,789
$5,567,557 31 Mar 2024
13F
SHEETS SMITH WEALTH MANAGEMENT
13F
Company
0.08%
945,720
$5,078,516 31 Mar 2024
13F
UBS Group AG
13F
Company
0.08%
925,489
$4,969,875 31 Mar 2024
13F
ALLEN HOLDING INC /NY
13F
Company
0.06%
687,571
$3,692,256 31 Mar 2024
13F
MORGAN STANLEY
13F
Company
0.06%
624,601
$3,354,108 31 Mar 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.05%
506,425
$2,719,502 31 Mar 2024
13F
Bank of New York Mellon Corp
13F
Company
0.04%
450,794
$2,420,764 31 Mar 2024
13F
Clearwater Capital Advisors, LLC
13F
Company
0.04%
443,299
$2,380,516 31 Mar 2024
13F
FRANKLIN RESOURCES INC
13F
Company
0.03%
391,752
$2,103,708 31 Mar 2024
13F
BARCLAYS PLC
13F
Company
0.03%
385,669
$2,071,041 31 Mar 2024
13F
HARBOURVEST PARTNERS LLC
13F
Company
0.03%
335,709
$1,802,757 31 Mar 2024
13F
BLAIR WILLIAM & CO/IL
13F
Company
0.03%
313,542
$1,683,721 31 Mar 2024
13F
JANE STREET GROUP, LLC
13F
Company
0.03%
308,138
$1,654,701 31 Mar 2024
13F
Skandinaviska Enskilda Banken AB (publ)
13F
Company
0.02%
270,950
$1,455,002 31 Mar 2024
13F
Sculptor Capital LP
13F
Company
0.02%
266,200
$1,429,494 31 Mar 2024
13F
Swiss National Bank
13F
Company
0.02%
263,100
$1,412,847 31 Mar 2024
13F
D. E. Shaw & Co., Inc.
13F
Company
0.02%
236,634
$1,270,725 31 Mar 2024
13F
Corient Private Wealth LLC
13F
Company
0.02%
221,530
$1,189,616 31 Mar 2024
13F
Deutsche Girozentrale DekaBank
13F
Individual
0.02%
205,092
$1,119,000 31 Mar 2024
13F
John C. Thomas
3/4/5
Former Director
class O/S missing
216,363
$1,086,143 31 Dec 2021
PROFUND ADVISORS LLC
13F
Company
0.02%
201,343
$1,081,212 31 Mar 2024
13F
RHUMBLINE ADVISERS
13F
Company
0.02%
186,875
$1,003,506 31 Mar 2024
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.02%
182,930
$982,334 31 Mar 2024
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.02%
178,930
$960,854 31 Mar 2024
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.01%
160,391
$861,300 31 Mar 2024
13F
Erste Asset Management GmbH
13F
Company
0.01%
153,000
$835,380 31 Mar 2024
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.01%
133,373
$716,213 31 Mar 2024
13F
China Universal Asset Management Co., Ltd.
13F
Company
0.01%
128,321
$689,084 31 Mar 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.01%
123,879
$667,000 31 Mar 2024
13F
Legal & General Group Plc
13F
Company
0.01%
115,146
$618,335 31 Mar 2024
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.01%
111,388
$598,154 31 Mar 2024
13F
MERIDIAN INVESTMENT COUNSEL INC.
13F
Company
0.01%
96,433
$517,845 31 Mar 2024
13F
Tidal Investments LLC
13F
Company
0.01%
92,839
$498,546 31 Mar 2024
13F
Winning Points Advisors, LLC
13F
Company
0.01%
92,786
$465,786 31 Mar 2024
13F
NATIONAL BANK OF CANADA /FI/
13F
Company
0%
55,311
$449,125 31 Mar 2024
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.01%
81,629
$438,348 31 Mar 2024
13F
Merit Financial Group, LLC
13F
Company
0%
43,812
$400,880 31 Mar 2024
13F

Institutional Holders of ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX) as of Q2 2024

As of 30 Jun 2024, ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX) was held by 188 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 61,630,296 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, JANE STREET GROUP, LLC, UBS ASSET MANAGEMENT AMERICAS LLC, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, JPMORGAN CHASE & CO, NORTHERN TRUST CORP, and GOLDMAN SACHS GROUP INC. This page lists 189 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
157
Q2 2024 holders
188
Holder diff
31
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 Value $ Q2 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.